|Articles|September 4, 2018
IRBM Signs Collaboration Agreement with Merck & Co.
Advertisement
IRBM, announced a new agreement in the peptide therapeutics area with Merck & Co. Inc., Kenilworth NJ USA, continuing their long-standing history of collaboration that began in 2010. This new agreement is focused on advancing peptide therapeutics.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
2
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
3
SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology
4
SCOPE Summit 2026: Elevating Patient Experience in Clinical Operations
5